share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  07/24 12:30
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/24/2024, with an aggregate market value of $1,113,688.80. The shares to be sold were acquired through restricted stock vesting on 02/20/2024 and 02/24/2024, as part of compensation from the issuer. Over the past three months, a total of 9,120 shares have been sold by the officer, generating gross proceeds of $4,292,375.60.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 07/24/2024, with an aggregate market value of $1,113,688.80. The shares to be sold were acquired through restricted stock vesting on 02/20/2024 and 02/24/2024, as part of compensation from the issuer. Over the past three months, a total of 9,120 shares have been sold by the officer, generating gross proceeds of $4,292,375.60.
Vertex药厂官员Carmen Bozic,计划于2024年07月24日卖出2,280股普通股,市值合计为$1,113,688.80。这些股份是作为薪酬的一部分,于2024年02月20日和02月24日获得的限制性股票。在过去的三个月中,该官员共售出9,120股股票,获得了4,292,375.60美元的总收入。
Vertex药厂官员Carmen Bozic,计划于2024年07月24日卖出2,280股普通股,市值合计为$1,113,688.80。这些股份是作为薪酬的一部分,于2024年02月20日和02月24日获得的限制性股票。在过去的三个月中,该官员共售出9,120股股票,获得了4,292,375.60美元的总收入。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息